Progyny (NASDAQ: PGNY) reported Q2 EPS of $0.55, $0.21 better than the analyst estimate of $0.34. Revenue for the quarter came in at $350.51 million versus the consensus estimate of $348.69 million.

FY2026 Outlook-

Revenue between $1.36 billion to $1.38 billion versus the consensus $1.38 billion.

EPS between $2.04 to $2.10 versus the consensus $2.06.

Q3 2026 Outlook-

Revenue between $335 million to $345 million versus the consensus $350.6 million.

EPS between $0.50 to $0.52 versus the consensus $0.52.

For earnings history and earnings-related data on Progyny (PGNY) click here.